SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-071761
Filing Date
2023-12-20
Accepted
2023-12-20 09:19:17
Documents
13
Period of Report
2023-12-15
Items
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bdsx-20231215.htm   iXBRL 8-K 50050
  Complete submission text file 0000950170-23-071761.txt   210538

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bdsx-20231215_pre.xml EX-101.PRE 13992
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bdsx-20231215.xsd EX-101.SCH 2897
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bdsx-20231215_def.xml EX-101.DEF 13836
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bdsx-20231215_lab.xml EX-101.LAB 21355
7 EXTRACTED XBRL INSTANCE DOCUMENT bdsx-20231215_htm.xml XML 6159
Mailing Address 2970 WILDERNESS PLACE SUITE 100 BOULDER CO 80301
Business Address 2970 WILDERNESS PLACE SUITE 100 BOULDER CO 80301 303-417-0500
BIODESIX INC (Filer) CIK: 0001439725 (see all company filings)

IRS No.: 203986492 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39659 | Film No.: 231499604
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)